‘Very reassuring’ data has been presented on COVID-19 vaccine safety in patients with rheumatic diseases at the 2021 virtual EULAR Congress. A dedicated EULAR COVID-19 Vaccination (COVAX) registry launched in February has provided the first evidence showing no real difference between vaccine side effects in patients with rheumatic diseases and the general population. Presenting the ...
Data on safety profile of COVID-19 vaccines in rheumatic disease patients ‘reassuring’
By Emma Wilkinson
9 Jun 2021